Healthcare & Life Sciences

Paratek

United States

series-c-plus

Stage

Investors

About

Paratek Pharmaceuticals develops novel antibiotics to address serious bacterial infections and antibiotic resistance.

Funding rounds, investor list, and risk signals — unlock with a subscription.